Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reverse Axillary Mapping as a Lymphedema Prevention Strategy in Breast Radiation Treatment Planning

NCT04292860 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.

NCT NCT04292860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04292860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reverse Axillary Mapping as a Lymphedema Prevention Strategy in Breast Radiation Treatment Planning
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Phase
Observational
Overall status
Withdrawn
Start date
May 31, 2021
Completion date
January 31, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lymphedema